NewEdge Advisors, LLC

Position in BNTX — BioNTech SE

CIK 1633516 NEW ORLEANS, LA

Position in BNTX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$6,606

+$296 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#245

of 282 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

NewEdge Advisors, LLC holds $47,755,733 across 102 Biotechnology names. BNTX ranks #65 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	18,435	$9,157,217
2	REGN	Regeneron Pharmaceuticals, Inc.	11,911	$7,426,984
3	NUVB	Nuvation Bio Inc.	1,231,733	$6,996,243
4	INCY	Incyte Corp	34,605	$3,922,822
5	PHAT	Phathom Pharmaceuticals, Inc.	203,962	$2,212,987
6	EXEL	Exelixis, Inc.	32,532	$1,770,066
7	BMRN	Biomarin Pharmaceutical Inc	27,287	$1,561,362
8	RPRX	Royalty Pharma plc	21,597	$1,210,943

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,606	71	0.0%	Shares	Sole	2026-08-12
2026-03-31	$6,310	71	-98.5%	Shares	Sole	2026-06-03
2025-12-31	$458,673	4,818	-25.1%	Shares	Sole	2026-02-18
2025-09-30	$634,422	6,433	-1.4%	Shares	Sole	2025-11-17
2025-06-30	$694,716	6,525	+255.6%	Shares	Sole	2025-08-14
2025-03-31	$167,095	1,835	+4487.5%	Shares	Sole	2025-05-15
2023-06-30	$4,317	40	-98.6%	Shares	Sole	2023-08-14
2023-03-31	$359,384	2,885	+1009.6%	Shares	Sole	2023-05-12
2022-12-31	$39,057	260	-83.9%	Shares	Sole	2023-02-14
2021-09-30	$439,513	1,610	+7.3%	Shares	Sole	2021-10-29
2021-06-30	$336,043	1,501	—	Shares	Sole	2021-07-22
No filing history on record for this holder in this stock.